SALURETIC EFFECT OF THE LOOP DIURETIC TORASEMIDE IN CHRONIC-RENAL-FAILURE - INTERDEPENDENCE OF ELECTROLYTE EXCRETION

被引:24
作者
KNAUF, H [1 ]
MUTSCHLER, E [1 ]
机构
[1] UNIV FRANKFURT,PHARMAKOL INST NAT WISSENSCHAFTLER,W-6000 FRANKFURT 1,GERMANY
关键词
chronic renal failure; electrolyte excretion; loop diuretic; rebound; renal function; Torasemide; tubulo-glomerular feedback;
D O I
10.1007/BF00315406
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of torasemide have been studied in 7 healthy controls and 9 patients with stable chronic renal failure of various degrees. After a control period of 3 days torasemide 20 mg i. v. caused a dramatic increase in diuresis and electrolyte excretion without affecting the glomerular filtration rate. The duration of action of torasemide, τ, averaged 6 h and was independent of the creatinine clearance, CLCR. When related to τ the drug-induced excretion of Cl-, Na+, K+, Ca2+ and Mg2+ showed strong linear dependence on CLCR. Both the kaliuresis and the calciuresis during τ were tightly correlated with the natriuresis over the broad range of CLCR. Similarly, the excretion of Mg2+ was dependent on the kaliuresis. The torasemide-induced kaliuresis amounted to 12% of natriuresis, as after furosemide. The kaliuretic effect of loop diuretics is smaller than that of the thiazides. After τ, e. g. over a 24 h period, kaliuresis was not correlated with natriuresis. The magnitude of the rebound effect was diminished with increasing renal impairment. © 1990 Springer-Verlag.
引用
收藏
页码:337 / 343
页数:7
相关论文
共 40 条
[1]   FUROSEMIDE IN PATIENTS WITH HEART-FAILURE - SHIFT IN DOSE-RESPONSE CURVES [J].
BRATER, DC ;
CHENNAVASIN, P ;
SEIWELL, R ;
BECK, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :182-186
[2]   CLINICAL-PHARMACOLOGY OF TORASEMIDE, A NEW LOOP DIURETIC [J].
BRATER, DC ;
LEINFELDER, J ;
ANDERSON, SA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (02) :187-192
[3]   RESPONSE TO FUROSEMIDE IN CHRONIC RENAL-INSUFFICIENCY - RATIONALE FOR LIMITED DOSES [J].
BRATER, DC ;
ANDERSON, SA ;
BROWNCARTWRIGHT, D .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (02) :134-139
[4]   ROLE OF VOLUME CONTRACTION IN HYPOCALCIURIC ACTION OF CHLOROTHIAZIDE [J].
BRESLAU, N ;
MOSES, AM ;
WEINER, IM .
KIDNEY INTERNATIONAL, 1976, 10 (02) :164-170
[5]   SODIUM HOMEOSTASIS IN CHRONIC RENAL-DISEASE [J].
BRICKER, NS ;
LEVINE, B ;
FINE, LG ;
DANOVITCH, GM ;
KOPPLE, JD ;
COHEN, JJ ;
REVER, BL ;
LICHT, A ;
KUROKAWA, K ;
KIRSCHENBAUM, MA ;
RODRIGUEZ, HJ .
KIDNEY INTERNATIONAL, 1982, 21 (06) :886-897
[6]  
CONSTANZO LS, 1978, AM J PHYSIOL, V235, pF492
[7]  
DELARGE J, 1974, ANN PHARM FR, V32, P657
[8]  
DELARGE J, 1978, ANN PHARM FR, V36, P369
[9]  
DODION L, 1986, EUR J CLIN PHARMACOL, V32, P49
[10]  
Epstein M, 1988, KIDNEY LIVER DIS, P3